RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Management and treatment of atopic dermatitis with modern therapies, complementary and alternative medicines: a review

      한글로보기

      https://www.riss.kr/link?id=A105932965

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Atopic dermatitis (AD) is a common dermatological disease characterized by relapsing pruritus and rash accompanied by cutaneous physiological dysfunction. This disease could affect certain population worldwide, including infants, children and adults. The prevalence of AD has been increased rapidly over the past few decades and the severity of the disease, symptoms, and effects on patients’ quality of life may vary among individuals. AD could be caused or triggered by several factors, such as genotypic, climatic, food allergens and environmental. Many treatments are available to alleviate the symptoms and severity of AD, including topical therapy, immunosuppressant and systemic therapy, phytotherapeutic approach, traditional Chinese medicine (TCM), as well as complementary and adjunct therapies. Topical therapies involve moisturizers, emollients, topical corticosteroids, topical pimecrolimus and tacrolimus and antipruitic/antihistamine therapy. Whereas, systemic therapies and immunosuppressant prescribed for AD treatment include cyclosporine A, azathioprine and methotrexate. Nowadays, not only the modern medicines are used for treatment of AD but also the phytotherapy using herbs and TCM are commonly incorporated into the therapy. In addition some studies have been showed that complementary/adjunct therapies are effective as preventive approaches for managing AD. In this review some examples of these therapies and approaches will be discussed with relevant supporting literatures.
      번역하기

      Atopic dermatitis (AD) is a common dermatological disease characterized by relapsing pruritus and rash accompanied by cutaneous physiological dysfunction. This disease could affect certain population worldwide, including infants, children and adults. ...

      Atopic dermatitis (AD) is a common dermatological disease characterized by relapsing pruritus and rash accompanied by cutaneous physiological dysfunction. This disease could affect certain population worldwide, including infants, children and adults. The prevalence of AD has been increased rapidly over the past few decades and the severity of the disease, symptoms, and effects on patients’ quality of life may vary among individuals. AD could be caused or triggered by several factors, such as genotypic, climatic, food allergens and environmental. Many treatments are available to alleviate the symptoms and severity of AD, including topical therapy, immunosuppressant and systemic therapy, phytotherapeutic approach, traditional Chinese medicine (TCM), as well as complementary and adjunct therapies. Topical therapies involve moisturizers, emollients, topical corticosteroids, topical pimecrolimus and tacrolimus and antipruitic/antihistamine therapy. Whereas, systemic therapies and immunosuppressant prescribed for AD treatment include cyclosporine A, azathioprine and methotrexate. Nowadays, not only the modern medicines are used for treatment of AD but also the phytotherapy using herbs and TCM are commonly incorporated into the therapy. In addition some studies have been showed that complementary/adjunct therapies are effective as preventive approaches for managing AD. In this review some examples of these therapies and approaches will be discussed with relevant supporting literatures.

      더보기

      참고문헌 (Reference)

      1 Chen H-Y, "Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study" 159 : 189-196, 2015

      2 Nomura Tet, "Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis" 119 : 434-440, 2007

      3 Fernandez-Guarino M, "Treatment ofmoderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy" 29 : 19-23, 2016

      4 Chan BCL, "Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells" 120 : 85-91, 2008

      5 Ormerod A, "Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?" 153 : 701-705, 2005

      6 Charman C, "Topical corticosteroid phobia in patients with atopic eczema" 142 : 931-936, 2000

      7 Trakultivakorn M, "Time trends of the prevalence of asthma, rhinitis and eczema in Thai children- ISAAC (international study of asthma and allergies in childhood) phase three" 44 : 609-611, 2007

      8 Armstrong N, "The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials" 48 : 262-, 1999

      9 Mancini AJ, "The socioeconomic impact of atopic dermatitis in the United States: a systematic review" 25 : 1-6, 2008

      10 Ahn K, "The role of air pollutants in atopic dermatitis" 134 : 993-999, 2014

      1 Chen H-Y, "Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study" 159 : 189-196, 2015

      2 Nomura Tet, "Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis" 119 : 434-440, 2007

      3 Fernandez-Guarino M, "Treatment ofmoderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy" 29 : 19-23, 2016

      4 Chan BCL, "Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells" 120 : 85-91, 2008

      5 Ormerod A, "Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?" 153 : 701-705, 2005

      6 Charman C, "Topical corticosteroid phobia in patients with atopic eczema" 142 : 931-936, 2000

      7 Trakultivakorn M, "Time trends of the prevalence of asthma, rhinitis and eczema in Thai children- ISAAC (international study of asthma and allergies in childhood) phase three" 44 : 609-611, 2007

      8 Armstrong N, "The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials" 48 : 262-, 1999

      9 Mancini AJ, "The socioeconomic impact of atopic dermatitis in the United States: a systematic review" 25 : 1-6, 2008

      10 Ahn K, "The role of air pollutants in atopic dermatitis" 134 : 993-999, 2014

      11 Wang X, "The prevalence of asthma and allergies in Singapore; data from two ISAAC surveys seven years apart" 89 : 423-426, 2004

      12 Cheng H-M, "The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, doubleblind, placebo-controlled trial" 155 : 141-148, 2011

      13 Salameh F, "The effectiveness of combined Chinese herbal medicine and acupuncture in the treatment of atopic dermatitis" 14 : 1043-1048, 2008

      14 Evangelista MT, "The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial" 53 : 100-108, 2014

      15 Teeratakulpisarn J, "Surveying the prevalence of asthma, allergic rhinitis and eczema in schoolchildren in Khon Kaen, Northeastern Thailand using the ISAAC questionnaire: phase III Asian Pacific" 22 : 175-, 2004

      16 Nomura T, "Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan" 128 : 1436-1441, 2008

      17 Coondoo A, "Side-effects of topical steroids: a long overdue revisit" 5 : 416-, 2014

      18 Arellano FM, "Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis" 127 : 808-816, 2007

      19 Ro ADB, "Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation" 47 (47): 1014-1021, 2017

      20 Pelucchi C, "Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis" 23 : 402-414, 2012

      21 Panduru M, "Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies" 29 : 232-242, 2015

      22 Kamer B, "Prevalence of atopic dermatitis in infants during the first six months of life: authors’ observations" 30 : 277-281, 2013

      23 Quah B, "Prevalence of asthma, eczema and allergic rhinitis: two surveys, 6 years apart, in Kota Bharu, Malaysia" 10 : 244-249, 2005

      24 Niccoli AA, "Preliminary results on clinical effects of probiotic lactobacillus salivarius LS01 in children affected by atopic dermatitis" 48 : S34-S36, 2014

      25 Foolad N, "Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children" 5 : 151-160, 2014

      26 Brown DJ, "Phytotherapeutic approaches to common dermatologic conditions" 134 : 1401-1404, 1998

      27 Rodenbeck DL, "Phototherapy for atopic dermatitis" 34 : 607-613, 2016

      28 Ho J, "Pediatric Skin of Color" Springer 427-437, 2015

      29 Schneider A, "P333 severe atopic dermatitis poorly responsive to standard treatments successfully treated with traditional chinese medicine" 117 : S120-, 2016

      30 Flohr C, "New insights into the epidemiology of childhood atopic dermatitis" 69 : 3-16, 2014

      31 Leung DY, "New insights into atopic dermatitis" 113 : 651-657, 2004

      32 Lee J, "Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis" 121 : 116-121, 2008

      33 Bogaczewicz J, "Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human ${\beta}$ defensin-1, interleukin-10, and interleukin-31" 55 (55): 2016

      34 Bogaczewicz J, "Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis" 55 : 856-863, 2015

      35 Rajeshwari U, "Medicinal benefits of coriander (Coriandrum Sativum L)" 1 : 51-58, 2011

      36 Sidbury R, "Management and treatment with phototherapy and systemic agents" 71 : 327-349, 2014

      37 Lyakhovitsky A, "Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults" 24 : 43-49, 2010

      38 Luger T, "Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis" 15 : 169-178, 2004

      39 Kapp A, "Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug" 110 : 277-284, 2002

      40 Williams H, "Is eczema really on the increase worldwide?" 121 : 947-954, 2008

      41 Deckers IA, "Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies" 7 : e39803-, 2012

      42 Zakaria ZA, "In vivo antinociceptive and anti-inflammatory activities of dried and fermented processed virgin coconut oil" 20 : 231-236, 2011

      43 Gensollen T, "How colonization by microbiota in early life shapes the immune system" 352 : 539-544, 2016

      44 Shenefelt PD, "Herbal medicine: biomolecular and clinical aspects" CRC Press/Taylor & Francis 2011

      45 Odhiambo JA, "Global variations in prevalence of eczema symptoms in children from ISAAC phase three" 124 : 1251-1258, 2009

      46 CooksonWO, "Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci" 27 : 372-, 2001

      47 Irvine AD, "Fleshing out filaggrin phenotypes" 127 : 504-507, 2007

      48 DaVeiga SP, "Epidemiology of atopic dermatitis: a review" 33 : 227-234, 2012

      49 Spergel JM, "Epidemiology of atopic dermatitis and atopicmarch in children" 30 : 269-280, 2010

      50 Simpson EL, "Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention" 134 : 818-823, 2014

      51 Sheehan M, "Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis" 340 : 13-17, 1992

      52 Roekevisch E, "Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review" 133 : 429-438, 2014

      53 Wahn U, "Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children" 110 : e2-e2, 2002

      54 Weston S, "Effects of probiotics on atopic dermatitis: a randomised controlled trial" 90 : 892-897, 2005

      55 Kim S-O, "Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials" 113 : 217-226, 2014

      56 Kim J, "Effects of Scutellariae radix and Aloe vera gel extracts on immunoglobulin E and cytokine levels in atopic dermatitis NC/Nga mice" 132 : 529-532, 2010

      57 Lee KC, "Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial" 30 (30): 8-11, 2011

      58 Foolad N, "Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids" 149 : 350-355, 2013

      59 Palmer D, "Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial" 344 : e184-, 2012

      60 Soon-Hee Lee, "Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice" 대한수의학회 11 (11): 35-41, 2010

      61 Akdis CA, "Diagnosis and treatment of atopic dermatitis in children and adults: European academy of Allergology and clinical immunology/American academy of allergy, asthma and immunology/PRACTALL consensus report" 61 : 969-987, 2006

      62 Khattri S, "Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology" 133 : 1626-1634, 2014

      63 Leslie TA, "Current topical and systemic therapies for itch" Pharmacology of Itch Springer 337-356, 2015

      64 박건혁, "Coriander Alleviates 2,4-Dinitrochlorobenzene-Induced Contact Dermatitis-Like Skin Lesions in Mice" 한국식품영양과학회 17 (17): 862-868, 2014

      65 Rubel D, "Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective" 40 : 160-171, 2013

      66 Palmer CN, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis" 38 : 441-446, 2006

      67 Gu SX, "Chinese herbal medicine for atopic eczema: an overview of clinical evidence" 28 (28): 246-250, 2017

      68 Gu S, "Chinese herbal medicine for atopic eczema" 9 : 2013

      69 Tan HY, "Chinese herbal medicine for atopic dermatitis: a systematic review" 69 : 295-304, 2013

      70 Lin J-F, "Characteristics and prescription patterns of traditional Chinese medicine in atopic dermatitis patients: ten-year experiences at a medical center in Taiwan" 22 : 141-147, 2014

      71 Berth-Jones J, "Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial" 147 : 324-330, 2002

      72 Meggitt SJ, "Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial" 367 : 839-846, 2006

      73 Morgenstern V, "Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children" 177 : 1331-1337, 2008

      74 Larsen FS, "Atopic dermatitis: a geneticepidemiologic study in a population-based twin sample" 15 : 487-494, 1986

      75 Boguniewicz M, "Atopic dermatitis: a disease of altered skin barrier and immune dysregulation" 242 : 233-246, 2011

      76 Casetti F, "Antimicrobial activity against bacteria with dermatological relevance and skin tolerance of the essential oil from Coriandrum sativum L. fruits" 26 : 420-424, 2012

      77 Vazquez B, "Antiinflammatory activity of extracts from Aloe vera gel" 55 : 69-75, 1996

      78 Intahphuak S, "Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oil" 48 : 151-157, 2010

      79 Reuter J, "Anti-inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test" 6 : 847-851, 2008

      80 Bass IIIPF, "Alternative medicine for atopic dermatitis: many patients with AD are turning to nontraditional treatments not backed by science" 31 : 30-32, 2014

      81 Naafs B, "Allergic skin reactions in the tropics" 24 : 158-167, 2006

      82 Pfab F, "Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis-a patient-and examiner-blinded, randomized, placebocontrolled, crossover trial" 67 : 566-573, 2012

      83 Chan Yet, "A study on the knowledge, attitudes and practices of Southeast Asian dermatologists in the management of atopic dermatitis" 35 : 794-, 2006

      84 Schram ME, "A randomized trial of methotrexate versus azathioprine for severe atopic eczema" 128 : 353-359, 2011

      85 Panahi Yet, "A randomized comparative trial on the therapeutic efficacy of topical aloe vera and Calendula officinalis on diaper dermatitis in children" 2012

      86 Boguniewicz M, "A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis" 6 : 416-423, 2007

      87 Finberg MJ, "A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice" 23 : 337-341, 2015

      88 Lewis-Jones M, "A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases" 155 : 145-151, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-02-27 학회명변경 한글명 : 한의학연구소 -> 융합한의과학연구소 KCI등재
      2016-10-01 평가 SCOPUS 등재 (기타) KCI등재
      2012-01-01 평가 등재후보 탈락 (기타)
      2011-12-06 학술지명변경 한글명 : oriental pharmacy -> Oriental Pharmacy and Experimental Medicine KCI등재
      2009-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2008-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2006-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0 0 0
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0 0 0 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼